Classifications

• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
  • C12N9/0004—Oxidoreductases (1.)
  • C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
• • C—CHEMISTRY; METALLURGY
  • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
  • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
  • C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
  • C08G63/02—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds
  • C08G63/06—Polyesters derived from hydroxycarboxylic acids or from polycarboxylic acids and polyhydroxy compounds derived from hydroxycarboxylic acids
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
  • C12N15/09—Recombinant DNA-technology
  • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
  • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
  • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
  • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
  • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
  • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
  • C12N9/10—Transferases (2.)
  • C12N9/1025—Acyltransferases (2.3)
  • C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
  • C12N9/10—Transferases (2.)
  • C12N9/1096—Transferases (2.) transferring nitrogenous groups (2.6)
• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
  • C12P7/00—Preparation of oxygen-containing organic compounds
  • C12P7/62—Carboxylic acid esters
  • C12P7/625—Polyesters of hydroxy carboxylic acids

Definitions

• poly- -hydroxybutyrate PHA
• PHA poly- -hydroxybutyrate
• n is 0 or an integer and R 1 , R 2 , R 3 , and R 4 are each selected from saturated and unsaturated hydrocarbon radicals; hal- and hydroxy-substituted radicals; hydroxy radicals; halogen radicals; nitrogen-substituted radicals; oxygen-substituted radicals; and hydrogen atoms,
• PHA polymers have the ability to accumulate intracellular reserves of PHA polymers. Since polyhydroxyalkanoates are natural thermoplastic polyesters, the majority of their applications are as replacements for petrochemical polymers currently in use for packaging and coating applications. The extensive range of physical properties of the PHA family of polymers, in addition to the broadening of performance obtainable by compounding and blending as traditionally performed in the polymer industry, provides a corresponding broad range of potential end-use applications.
• the PHAs can be produced in a wide variety of types depending on the hydroxyacid monomer composition
• This wide range of polymer compositions reflects an equally wide range of polymer physical properties including: a range of melting temperatures from 40°C-180°C, glass transition temperatures from -35 to 5°C, degrees of crystallinity of 0% to 80% coupled with the ability to control the rate of crystallization and elongation to break of 5 to 500%.
• Poly(3- hydroxybutyrate) for example, has characteristics similar to those of polypropylene while poly(3-hydroxyoctanoate) (a copolymer of (R)-3- hydroxyoctanoate and (R -3-hydroxyhexanoate) types behave more as elastomers and PHAs with longer side chains giving behavior closer to waxes.
• the PHAs can also be plasticized and blended with other polymers or agents.
• One particularly useful form is as a latex of PHA in water.
• the monomer compositions also affect solubility in organic solvents allowing for a choice of a wide range of solvents.
• Copolymers of (R)-3-hydroxybutyrate and other hydroxyacid comonomers have significantly different solubility characteristics from those of the PHB homopolymer.
• PHAs have seen limited commercial availability with only the copolymer poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) being available in significant quantities.
• This copolymer has been produced by fermentation of the bacterium Ralstonia eutropha (formerly Alcaligenes eutrophus). Fermentation processes for other PHAs have been developed (Williams and Peoples, 1996, CHEMTECH 26: 38-44). Plant crops are also being genetically engineered to produce these polymers, and offer a cost structure in line with the vegetable oils and direct price competitiveness with petroleum based polymers (Williams and Peoples 1996, CHEMTECH 26: 38-44).
• polyesters have been manufactured using methods similar to that originally described for PHBV in which the microorganisms are fed a relatively expensive non-carbohydrate feedstock in order to force the incorporation of the monomer into the PHA polyester.
• production of PHB4HB has been accomplished by feeding glucose and 4-hydroxybutyrate or substrate that is converted to 4-hydroxybutyrate to A. eutrophus (Kunioka, M. , Nakamura, Y. , and Doi, Y. 1988, Polym. Commun.
• Substrates that are converted to 4-hydroxybutyrate are 1 ,4-butanediol, 1,6-hexanediol, 1,8- octanediol, 1,10-decanediol, 1,12-dodecanediol and 1,4-butyrolactone.
• the PHB4HB copolymers can be produced with a range of monomer compositions which again provides a range of polymer properties. In particular as the amount of 4HB increases above 10 wt. %, the melting temperature (T m ) decreases below 130°C and the elongation to break increases above 400% (Saito, Y., Nakamura, S. , Hiramitsu, M. and Doi, Y. , 1996, Polym. Int. 39: 169).
• PHA4HB was achieved in E. coli using the 4-hydroxybutyrate pathway from C. kluyve ⁇ (Hein, S., S ⁇ hling, B., Gottschalk, G. , and Steinbuchel, A.
• a further object of the present invention is to provide techniques and procedures to stably engineer transgenic organisms that synthesize PHAs containing 4-hydroxybutyrate either as sole constituent or as co- monomer.
• Transgenic E. coli strains are described in which the required phb genes have been integrated on the chromosome. Additional genes for the synthesis of the 4HB monomer are also integrated on the chromosome. The latter genes can be derived from a broad range of organisms which carry a 4-hydroxybutyryl-CoA transferase and be identified by screening for this activity in the engineered E. coli strains described here. In addition, an endogenous E. coli activity is disclosed that can be further improved for the purpose of 4HB-CoA transferase activity.
• New pathways are also disclosed for the supply of intermediates of 4HB biosynthetic pathways such as ⁇ -ketoglutarate and ⁇ - aminobutyrate.
• the diversity of these pathways is important for the successful production of 4HB containing PHAs from cheap carbon sources such as sugars and fatty acids.
• Figure 1 A is the alignment of the C. kluyveri OrfZ sequence with the N-terminal sequence and internal sequences of 4-hydroxybutyryl CoA transferase (4HBCT) from C. aminobutyricum (SEQ LD Nos 1 and 2. Identical residues are indicated, similar residues are indicated by *.
• Figures IB and 1C are the nucleotide sequence of the or Z gene from C. kluyeri.
• Figure ID is the amino acid sequence of the orfL gene from C. isseyeri.
• Figure 2 is a schematic of the endogenous synthesis of 4- hydroxybutyryl CoA from ⁇ -ketoglutarate through the GAB A shunt. 1. ⁇ - ketoglutarate aminotransferase; 2. glutamate decarboxylase; 3. GAB A transaminase; 4. Succinic semialdehyde reductase; 5. 4-hydroxybutyryl CoA transferase.
• FIG 3 is a schematic of the endogenous synthesis of 4- hydroxybutyryl-CoA from GAB A precursors.
• GABA is an intermediate in the degradation of amino acids such as arginine, glutamine and proline. Genes in arginine degradation are encoded by speA, adi, speB,pat zva ⁇ prr; genes in glutamine degradation are encoded by gltBD and gadB, genes in proline degradation are encoded by putA and gadB.
• GABA is converted to 4-hydroxybutyryl-CoA by the gene products of gabT, 4hbD and hbcT.
• Figure 4 is a schematic of the endogenous synthesis of 4- hydroxybutyryl CoA from succinate. 1. succinyl CoA-CoA transferase; 2. succinate semialdehyde dehydrogenase; 3. 4-hydroxybutyrate dehydrogenase; 4. 4-hydroxybutyryl CoA transferase.
• Figure 5 is a schematic of the construction of plasmids for integration of the PHB synthase (phbC) gene from Z ramigera into the chromosome of E. coli and other Gram-negative bacteria.
• phbC PHB synthase
• Figures 6 and 6 A are a schematic of the construction of plasmids for integration of 3-ketoacyl-CoA thiolase (phbA) and acetoacetyl-CoA reductase (phbB) genes from Z. ramigera into the chromosome of E. coli and other Gram-negative bacteria.
• phbA 3-ketoacyl-CoA thiolase
• phbB acetoacetyl-CoA reductase
• Figure 7 is a schematic of the metabolic and genetic representation of the engineered biosynthetic pathway for 4-hydroxybutyryl-CoA synthesis.
• the gene products of gabT, 4hbD and hbcT are required for this pathway, gadAB and gdhA are helpful, whereas the gene products oiaspC, sad and gabD are preferably absent or inactive.
• Figure 8 is a schematic of the construction of plasmids pMSX-TD and pMSXTpl-TD, which expresses enzymes to convert ⁇ -ketoglutarate to 4-hydroxybutyryl-CoA.
• Figure 9 is a schematic of the construction of plasmids pMSX-ABT, pMSXTpl-ABT and pMSXTpl-BT, which expresses enzymes to convert ⁇ - ketoglutarate to 4-hydroxybutyryl-CoA.
• RECTIFI Figure 10 is a schematic of the construction of plasmid pMSX- ABT and pMSX-ABT-TD which expresses enzymes to convert - ketoglutarate to 4-hydroxybutyryl-CoA.
• Figure 11 is a schematic of the construction of plasmid pMSX- TIDD which expresses enzymes to convert succinate to 4-hydroxybutyryl- CoA
• transgenic organisms that synthesize PHAs containing 4-hydroxybutyrate either as sole constituent or as co-monomer have been developed.
• the transgenic organism is either a bacterium eg. Escherichia coli, K. pneumoniae, Ralstonia eutropha (formerly Alcaligenes eutrophus), Alcaligenes latus or other microorgamsms able to synthesize PHAs, or a higher plant or plant component, such as the seed of an oil crop (Brassica, sunflower, soybean, corn, safflower, flax, palm or coconut or starch accumulating plants (potato, tapioca, cassava).
• an oil crop Brassica, sunflower, soybean, corn, safflower, flax, palm or coconut or starch accumulating plants (potato, tapioca, cassava).
• a screening procedure for the identification of genes encoding enzymes capable of converting 4-hydroxybutyric acid to 4-hydroxybutyryl-CoA and methods for redirecting the flux of normal cellular metabolites such as e.g. succinic acid and/ or glutamic acid to 4-hydroxybutyric acid has been developed.
• the gene encoding a 4-hydroxybutyryl CoA transferase gene from the Gram-positive, strict anaerobic bacterium Clostridium kluyveri has been identified and used to express this enzyme activity in a transgenic organism to convert 4-hydroxybutyric acid into 4- hydroxybutyryl-CoA resulting in the accumulation of poly(4- hydroxybutyrate) in E. coli.
• a bacteria expressing a functional PHA synthase from a transgene is described, as well as methods for expressing these genes in transgenic plant crops. Screening systems for new 4-hydroxybutyryl CoA transferase encoding genes are also described.
• Transgenic E. coli strains in which a PHA synthase encoding gene is integrated in the chromosome and expressed to levels supporting PHA synthesis have been developed. With these transgenic strains can be screened with genomic libraries from different biological sources for activities that convert alternative PHA precursors such as 4-hydroxybutyrate to corresponding substrates for PHA synthase.
• a similar approach in metabolic engineering can accommodate production of 4HB containing PHAs in organisms such as A. eutrophus, A. latus and Comamonas which are currently capable of producing 4-hydroxybutyrate copolymers from cosubstrates and in transgenic microbial and plant crop systems expressing a PHA synthesis from a heterologous PHA synthase gene or genes.
• the genes of interest can be expressed from extrachromosomal DNA molecules such as plasmids, which intrinsically results in a copy number effect and consequently high expression levels, or, more preferably, they can be expressed from the chromosome.
• extrachromosomal DNA molecules such as plasmids
• plasmids which intrinsically results in a copy number effect and consequently high expression levels
• they can be expressed from the chromosome.
• plasmid-based systems are unsatisfactory due to the extra burden of maintaining the plasmids and the problems of stable expression.
• the minimal requirements for the synthesis of these PHAs in vivo includes a gene encoding 4-hydroxybutyrate CoA transferase or similar activity and 4- hydroxybutyrate.
• the substrate 4-hydroxybutyrate can be administered to the PHA producing microorganism or be synthesized in vivo by engineered biosynthetic pathways from appropriate substrates. Amino acid sequence was determined for the purified 4-hydroxybutyrate CoA transferase (Scherf and Buckel, Appl. Environ. Microbiol. (1991) 57:2699-2701).
• the purified protein was subjected to enzymatic digestion followed by amino acid sequence analysis of three of the resulting peptides.
• the amino acid sequence of these peptides and the N-terminus of the intact protein showed a striking homology to the OrfZ gene product ( Figures 1 A, IB, 1C, and ID), whose identity and function was not known, thereby identifying orfZ as the gene encoding 4-hydroxybutyryl CoA transferase in C. khiyveri. This gene was renamed hbcT.
• coli strain MBX777 contains the genes encoding ⁇ -ketothiolase, acetoacetyl CoA reductase and PHB synthase from Z ramigera. Upon introduction of a plasmid encoding hbcT and supplying 4-hydroxybutyrate in the growth medium, a PHB-4HB copolymer was formed.
• 4-hydroxybutyrate is synthesized from endogenous intermediates instead of being supplied externally.
• Two biochemical routes to the precursor 4HB-CoA can be established in a production organism for 4HB- containing PHAs. The first pathway proceeds from ⁇ -ketoglutarate, the second from succinate. Substrate for both pathways can also be provided through amino acid degradation.
• Pathway to 4-hydroxybutyryl CoA from ot-ketoglutarate A pathway that enables the conversion of ⁇ -ketoglutarate to 4- hydroxybutyryl CoA is shown in Figure 2. Enzymes involved in this pathway are cc-ketoglutarate transaminase, glutamate dehydrogenase, glutamate decarboxylase, 4-hydroxybutyrate dehydrogenase and 4- hydroxybutyrate CoA transferase.
• Genes encoding these activities can be acquired from multiple sources: gdhA gene encoding glutamate dehydrogenase: E. coli (Valle et al. Gene (1984) 27: 193-199 and Valle et al., Gene (1983) 23: 199-209), Klebsiella aerogenes (Mountain et al. , Mol. Gen. Genet. (1985) 199: 141- 145), Pyrococcus furiosus (DiRuggiero et al. , Appl. Environ. Microbiol. (1995) 61: 159-164; Eggen et al.
• Glutamate dehydrogenase (Syntichaki et al. (1996) Gene 168: 87- 92), maize (Sakakibara et al. (1995), Plant Cell Physiol. 36: 789-797), human (Tzimagiogis et al. (1993), Hum. Genet. 91: 433-438), mouse (Tzimagiogis et al. (1991), Biochem. Biophys. Acta 1089: 250-253), Amuro et al. (1990), Biochem. Biophys. Acta 1049: 216-218).
• ⁇ -ketoglutarate transaminase (Park et al. (1993), J. Biol. Chem.
• the gab gene cluster is only expressed at low constitutive levels due to catabolite repression by glucose and ammonia. When a poor nitrogen source or succinate as carbon source are supplied the operon is derepressed.
• both cAMP/CRP and NtrC regulate the promoter, in addition to a specific repressor encoded by gabC.
• the promoter that regulates gabT is located upstream of gabD.
• Succinate semialdehyde dehydrogenases are encoded by gabD and sad. These activities could be deleterious for the purpose of P4HB or PHB-4HB production although their expression is expected to be repressed by the presence of sufficient glucose and nitrogen sources.
• Glutamate decarboxylase is a rare enzyme among the ⁇ nterobacteriacea. It is pyridoxal phosphate dependent and well expressed at low pH. Pathways to 4-hydroxybutyryl-CoA from arginine, putrescine, glutamine and proline via GABA
• Bacteria such as Escherichia coli are capable of catabolizing at least four different amino acids (arginine, proline, glutamine, and glutamate) to produce GABA, which can be converted as described above to 4-hydroxy-butyryl-CoA. These catabolic pathways are depicted in Figure 3.
• E. coli contains at least two activities, encoded by speA and adi, that can decarboxylate arginine to agmatine.
• Putrescine and urea are formed from agmatine by the action of agmatine ureohydrolase, encoded by speB.
• Putrescine donates an amino group to ⁇ -ketoglutarate to form 4- aminobutyraldehyde and glutamate in a reaction catalyzed by the product of the pat gene, putrescine aminotransf erase.
• the 4-aminobutyraldehyde is oxidized to GABA by aminobutyraldehyde dehydrogenase, encoded by prr.
• agmatine ureohydrolase putrescine aminotransf erase, and aminobutyraldehyde dehydrogenase is dually controlled by catabolite repression and nitrogen availability. Catabolite repression of agmatine ureohydrolase, but not that of putrescine aminotransf erase or aminobutyraldehyde dehydrogenase, can be relieved by cAMP.
• Agmatine ureohydrolase synthesis is induced by arginine and agmatine.
• Arginine decarboxylase synthesis is not sensitive to catabolite repression or to stimulation by nitrogen limitation or subject to substrate induction (Shaibe et al., J. Bacteriol.
• Proline is degraded in E. coli by the product of the put A gene, which catalyzes successive oxidations of proline to pyrroline 5-carboxylate and then to glutamate.
• the first step is FAD-dependent, and thus the PutA protein is membrane-associated.
• This same protein also acts as a repressor of the put operon in the absence of proline.
• the put operon is subject to catabolite repression (McFall and Newman, pp. 358-379, in Neidhardt, ed., Escherichia coli and Salmonella typhimurium: cellular and molecular biology, ASM Press, Washington, D.C. , 1996).
• Glutamine is converted to glutamate in E. coli by glutamate synthase, the product of the gltB and gltD genes. Two molecules of glutamate are formed by the donation of an amino group by glutamine to ⁇ -ketoglutarate.
• the activity of E. coli glutamate synthase is high when this organism is grown in ammonia-containing minimal medium and low when it is grown in the presence of glutamate or glutamate-generating nitrogen sources if nitrogen is limiting (Reitzer, pp. 391-407, in
• oat Avena sativa
• Brassicaceae Barbarea vulgaris, Nasturtium ojflcinale, Arabis drummondii, Aethionema grandiflora, Capsella bursa-pastoris, Arabidopsis arenosa, Sisymbrium altissimum, Thellungiella salsuginea, Polanisia dodecandra, Stanley a pinnata, Carica papaya, Brassica oleracea, Brassica nigra, Theobroma cacao) (Galloway et al. , Mol.
• gltBD encoding glutamate synthase: Escherichia coli (Oliver et al. , Gene 60: 1, 1987), Aquifex aeolicus (Deckert et al. , Nature 392:353,
• Haemophilus influenzae (Fleischmann et al., Science 269:496, 1995), Escherichia coli (Blattner et al. , Science 277: 1453, 1997), baker's yeast (Saccharomyces cerevisiae) (Science 265:2077, 1994), Vibrio alginolyticus (Nakamura et al. , Biochim. Biophys. Acta 1277:201, 1996), Pseudomonas aeruginosa (Savoiz et al. , Gene 86:107, 1990), Klebsiella pneumoniae (Chen and Maloy, J. Bacteriol.
• arginine, proline, glutamine, or glutamate can be supplied exogenously to the poly(4-hydroxybutyrate)-producing organism, or it can be synthesized in the host from another carbon source, preferably an inexpensive one such as glucose. E. coli, for example, synthesizes all of these compounds from glucose, but generally only to an extent sufficient for growth.
• E. coli that overproduce these compounds have been developed.
• Tujimoto et al. (U.S. Patent 5,378,616) describe an E. coli mutant that accumulates glutamate.
• Momose et al. (U.S. Patent 4,430,430) describe the overexpression of the argA gene in E. coli, which leads to arginine accumulation.
• Proline-resistant mutants of E. coli that overexpress proline synthesis genes can accumulate proline (Wang et al., Chin. J. Biotechnol. 6:27, 1990). Tobacco plants which overexpress bacterial proline synthesis genes were also shown to accumulate proline (Sokhansandzh et al. , Genetika 33:906, 1997).
• E. coli and other bacteria accumulate glutamate, GABA, and proline as a response to high medium osmolarity (McLaggan et al. , J. Biol. Chem. 269: 1911, 1994; Measures, J.C. , Nature 257:398, 1975; Schleyer et al. , Arch. Microbiol. 160:424, 1993; Botsford et al. , Appl. Environ. Microbiol. 60:2568, 1994).
• glutamate-succinic semialdehyde transaminase genes can be isolated from gene libraries because of the ability of this gene to complement an E. coli gabT mutation for utilization of ⁇ -aminobutyric acid as nitrogen source.
• mutations in glutamate dehydrogenase and glutamate decarboxylase genes in E. coli can be complemented.
• Expression of alternative 4-hydroxybutyrate dehydrogenase genes will allow E. coli to utilize 4-hydroxybutyrate as a carbon source.
• Enzyme homology searches using the BLASTP program and the GenBank database suggest the presence of 4-hydroxybutyrate dehydrogenase homologs in the E. coli genome. These proteins have been identified with the genetic index numbers: gi
• Example 1 Minimal requirements for PHB-4HB synthesis
• PHA poly-(R-3-hydroxybutyrate)
• PHA poly-(R-3-hydroxybutyrate)
• 4-Hydroxybutyryl-CoA can be prepared in situ from acetyl-CoA and 4- hydroxybutyrate via a transthioesterification reaction catalyzed by the enzyme 4-hydroxybutyryl-CoA transferase, isolated from Clostridium aminobutyricum. This enzyme will also catalyze the formation of (R)-3- hydroxybutyryl-CoA from the free acid and acetyl-CoA.
• Example 2 Poly (4-hydroxybutyrate) (P4HB) synthesis in E. coli using a plasmid encoded pathway
• the hbcT gene from C. kluyveri was expressed in E. coli using standard molecular biological techniques.
• the gene is placed in an appropriate vector behind a strong promoter and under conditions that drive expression from this promoter. 4HBCT is produced.
• Strains of E. coli were equipped with plasmid pFS30 which contains the genes encoding 4-hydroxybutyryl-CoA transferase from C. kluyveri and PHB synthase from R. eutropha. Theses genes are expected to convert 4-hydroxybutyric acid into 4-hydroxybutyryl-CoA which is subsequently polymerized to poly(4-hydroxybutyrate).
• Strains were grown in 250 ml Erlenmeyer flasks containing 50 to 100 ml 10% LB liquid medium with 4-hydroxybutyrate, alone or in combination with glucose, as carbon source. Cultures were incubated at 30 to 33 ° C with shaking at 150 or 200 rpm. Cultures were harvested after 24 hours of incubation and analyzed for PHA.
• E. coli MBX1177 (a spontaneous mutant of strain DH5 ⁇ selected for growth on minimal 4-HB medium) with pFS30 accumulates 67% of its cell dry weight as a P4HB homopolymer: host volume rpm 4HB glc T %LB %PHA F(4HB)
• Example 3 Poly (4-hydroxybutyrate) (P4HB) synthesis in E. coli using a plasmid encoded PHA synthase.
• Strains of E. coli were equipped with plasmid pFS16, which contains the gene encoding 4-hydroxybutyryl-CoA transferase from C. kluyveri. This gene is expected to convert 4-hydroxybutyric acid into 4- hydroxybutyryl-CoA which is subsequently polymerized by a chromosomally encoded PHB synthase into P4HB.
• Strains were grown in 250 ml Erienmeyer flasks containing 50 to 100 ml 10% LB or 100% LB liquid medium with 4-hydroxybutyrate, alone or in combination with glucose, as carbon source. Cultures were incubated at 32 to 37 °C with shaking at 0 to 250 rpm.
• Plasmid pMUXCscat contains the phbC gene from Z ramigera on a transposable element for integration of this gene on the chromosome of a recipient strain ( Figure 5). Strong translational sequences were obtained from pKPS4 which encodes PHA synthase encoding phaCl from . oleovorans in the pTrc vector (Pharmacia). In this construct, phaCl is preceded by a strong ribosome binding site: AGGAGGTTTTT(-ATG).
• the phaCl gene including the upstream sequences, was cloned as a blunt ended EcoRI-Hindlll fragment in the Smal site of pUC 18 Sfi to give pMSXC 3 .
• a blunt ended cat gene cassette was subsequently cloned in the blunt-ended Sse8387II site, resulting in pMSXC 3 cat.
• all of the phaCl coding region except the 5' 27 base pairs were removed as a Pstl-BamHI fragment and replaced by the corresponding fragment from the phbC gene from Z ramigera.
• the resulting plasmid, pMSXC 5 cat encodes a hybrid PHB synthase enzyme with the 9 amino terminal residues derived from the P. oleovorans PHA synthase and the remainder from Z ramigera.
• the C 5 cat cassette was then excised as anAvrll fragment and cloned in the corresponding sites of pUTHg, thereby deleting the mercury resistance marker from this vector.
• the resulting plasmid, pMUXC 5 cat contains a Cscat mini-transposon in which phbC is not preceded by a promoter sequence. Expression of the cassette upon integration is therefore dependent on transcriptional sequences that are provided by the DNA adjacent to the integration site.
• pMSXTpiAB 5 kan2 was constructed from pMSXTpikan as follows
• pMSXABscat was created by inserting a promoterless cat cassette in the Hindlll site of pMSXAB 5 .
• the AB5 fragment from pMSXAB 5 cat was cloned as a EcoRI- Pstl fragment into the Smal site of pMSXTp ⁇ kan2 giving P MSXTp 1 AB 5 kan2.
• Expression o ⁇ phbABS was improved by introduction of a strong promoter upstream of these genes ( Figures 6 and 6A).
• This promoter was generated with sets of oligonucleotides that provide upstream activating sequences, a -35 promoter region, a -10 promoter region with transcriptional start site(s), and mRNA sequences with possible stabilizing functions.
• Plasmid pMSXTpi AB 5 kan2 was digested with PstllXbal and a fragment containing the -10 region of the lac promoter was inserted as a fragment obtained after annealing oligonucleo-tides 3A (5 'GGCTCGTATAATGTGTGGAGGGAGAACCGCCGGGCTCGCCGTT) and
• 3B (5' CTAGAACGGCGCGAGCCCGGCGGTTCTCCCTCCACA CATTATACGA GCCTGCA).
• a fragment containing a consensus E. colipho box and -35 promoter region were inserted into the Pstl site as a fragment obtained after annealing the oligonucleotides: 2 A: (5' TCCCC TGTCATAAAGTTGTCACTGCA) and 2B (5' GTGACAACTTTATGACAGGGG ATGCA).
• the messenger stabilizing sequence including the transcriptional start site from AB 5 was inserted into the Xbal-Ndel sites as a fragment obtained after annealing the oligonucleotides: 4A (5 ' : CTAGTGCCGG
• the resulting plasmid is pMSXp ⁇ 2 AB 5 kan2.
• the Avrll fragment, containing Tp ⁇ 2 AB 5 kan2 was cloned into pUTHg cut with Avrll and used for integration into the genome of MBX379 and MBX245.
• DNA manipulations were performed on plasmid and chromosomal DNA purified with the Qiagen plasmid preparation or Qiagen chromosomal DNA preparation kits according to manufacturers recommendations. DNA was digested using restriction enzymes (New England Biolabs, Beverly, MA) according to manufacturers recommendations. DNA fragments were isolated from 0.7% agarose- Tris/acetate/EDTA gels using a Qiagen kit. Plasmid DNA was introduced into E. coli cells by transformation or electroporation (Sambrook et al.
• phb genes from the pUT vectors was achieved by mating of the plasmid donor strain and the recipient (Herrero et al. J. Bacteriol. (1990) 172: 6557).
• the recipient strains used were spontaneous naladixic acid or rifampicin resistant mutants of E. coli derived from either LS5218 or MBX23.
• MBX23 is LJ14 rpoS: :Tnl0 in which the rpoS: :Tnl0 allele was introduced by PI transduction from strain 1106 (Eisenstark).
• Recipients in which phb genes have been integrated into the chromosome were selected on naladixic acid or rifampicin plates supplemented with the antibiotic resistance specified by the mini-transposon, kanamycin or chloramphenicol. Oligonucleotides were purchased from Biosynthesis or Genesys. DNA sequences were determined by automated sequencing using a Perkin-Elmer ABI 373A sequencing machine. DNA was amplified using the synthase-chain- reaction in 50 microliter volume using PCR-mix from Gibco-BRL (Gaithersburg, Md) and an Ericomp DNA amplifying machine.
• Accumulated PHA was determined by gas chromatographic (GC) analysis as follows. About 20 mg of lyophilized cell mass was subjected to simultaneous extraction and butanolysis at 110°C for 3 hours in 2 mL of a mixture containing (by volume) 90% 1-butanol and 10% concentrated hydrochloric acid, with 2 mg/mL benzoic acid added as an internal standard. The water-soluble components of the resulting mixture were removed by extraction with 3 mL water.
• GC gas chromatographic
• the organic phase (1 ⁇ L at a split ratio of 1:50 at an overall flow rate of 2 mL/min) was analyzed on an HP 5890 GC with FID detector (Hewlett-Packard Co, Palo Alto, CA) using an SPB-1 fused silica capillary GC column (30 m; 0.32 mm ID; 0.25 ⁇ m film; Supelco; Belief onte, Pa.) with the following temperature profile: 80 °C, 2 min; 10 C° per min to 250 °C; 250 °C, 2 min.
• NTG l-Methyl-3-nitro-l-nitroso-guanidine
• Results C 5 cat was introduced into the chromosome of MBX23 by conjugation using S17-1 ⁇ pir (pMUX cat) the donor strain.
• the conjugation mixture was spread on LB/Nl/Cm plates and integrants were obtained of which 40% were sensitive to ampicillin, indicating that no plasmid was present in these strains.
• Five integrants were transformed with pMSXAB 5 cat (Ap r ) and grown on LB/Ap/Cm/2% glucose to examine biosynthetic activity of PHB synthase.
• MBX326 expressed the highest synthase activity and was used in further studies.
• E. coli SI 7-1 ⁇ pir containing pMUXp i2 AB 5 kan was mated with MBX379.
• Transgenic strains in which phbABJcan had integrated on the chromosome were selected on LB/Nl/Km plates.
• PHB producers were identified on LB/glucose plates and MBX677
• MBX379 : p 12 AB 5 kan
• the PHB level in this strain grown in Luria-Bertani/2 % glucose medium was 58% whereas 38% PHB was accumulated in minimal medium supplemented with 2% glucose.
• Example 6 Mutagenesis of transgenic E. coli strains for enhanced PHB production. Mutagenesis using NTG or EMS was used to improve PHB formation in MBX680. Strain MBX769 and MBX777 were selected after treatment of MBX680 with EMS and NTG respectively. These strains are able to grow on R2-medium supplied with 1 % glucose, 0.5% corn steep liquor and 1 mg/ml chloroamphenicol.
• MBX769 was grown in 50 ml R-10 medium/ 0.5% CSL with 2 or 3 % glucose at 37 °C for 20 to 26 hours. PHB was accumulated to 71 % of the cell dry weight. Similarly, MBX769 was grown in 50 ml LB with or without 0.375 g/L KH 2 PO 4 , 0.875 K 2 HPO 4 and 0.25 (NH 4 ) 2 SO 4 and a total of 50 g/L glucose (five aliquots were added over the course of the incubation). After 63 hours of incubation, PHB had accumulated up to 96% of the cell dry weight. PHB levels in MBX777 strain grown in Luria-Bertani/2 % glucose medium was 67% whereas in minimal medium supplemented with 2% glucose 57% PHB was accumulated.
• E. coli strains with a chromosomal phbC gene were obtained by PI transduction of the C5cat allele from MBX379 into LS5218, LS5218 / ⁇ ⁇ ; ⁇ /: :TnlO and LS5218 / ⁇ rfR + zcfll7: :TnlO.
• the resulting strains are MBX816, MBX817 and MBX821, respectively.
• Example 7 Poly (4-hydroxybutyrate) (P4HB) synthesis in E. coli using an endogenous 4-hydroxybutyryl-CoA transferase activity.
• E. coli contains an endogenous gene encoding an enzyme with 4- hydroxybutyryl-CoA transferase activity.
• Strains MBX821 and 1231 were grown in 250 ml Erienmeyer flasks containing 50 to 100 ml 10% LB liquid medium with 4-hydroxybutyrate, alone or in combination with glucose, as carbon source.
• MBX1231 is a mutant of MBX821 obtained after treatment with l-methyl-3-mtro-l-nitrosoguanidine and selected on plates containing 500 ⁇ g/ml chloramphenicol. Cultures were incubated at 32 to 33 °C with shaking at 200 rpm. Cultures were harvested after 24 hours of incubation and analyzed for PHA. Table x shows that these strains accumulate 2.5 to 3.5% of the cell dry weight as a P4HB homopolymer.
• P4HB formation in this strain is not dependent on a plasmid encoded PHB synthase nor a heterologously expressed 4- hydroxybutyryl-CoA transferase.
• P4HB levels are improved to around 11 %.
• Example 8 A screening method for air insensitive 4-hydroxybutyryl CoA transferase
• the 4-hydroxybutyryl-CoA transferase from C. kluyveri appears to be inhibited by air, most likely by oxygen.
• Oxygen insensitive mutants can be screened for by growing mutants of an E. coli strain that harbors the 4-hydroxybutyryl-CoA transferase encoding hbcT gene on a plasmid and a PHA synthase gene on the chromosome, for P4HB synthesis under high oxygenation conditions and searching for white colonies (indicative of PHA accumulation) where the majority of the population forms grey colonies.
• Oxygen insensitive strains, MBX240 [pFS16], MBX379 [pFS16] and MBX830 [pFS16] were identified using this method.
• mutants can be generated in vivo by treating the original strain with chemical mutagens such as N-methyl-N'-nitro-N- nitrosoguanidine or ethylmethanesulfonate or with ultraviolet radiation.
• chemical mutagens such as N-methyl-N'-nitro-N- nitrosoguanidine or ethylmethanesulfonate or with ultraviolet radiation.
• an hbcT containing plasmid can be mutagenized in vitro with hydroxylamine.
• Mutants expressing a functional 4-hydroxybutyryl- CoA transferase are then screened for on solid media or highly oxygenated liquid media for P4HB formation from 4-hydroxybutyrate.
• Example 9 A screening method for additional E. coli genes encoding 4- hydroxybutyryl CoA biosynthetic enzymes
• Expression of the enzymatic activity that converts 4HB to 4HB- CoA in MBX821 or 1231 may be elevated by mutagenesis. Appearance of P4HB in MBX821 and 1231 grown on solid media took approximately 150 hours. Mutants with improved P4HB accumulation characteristics can be screened for after random mutagenesis of these strains with chemical mutagens such as N-methyl-N'-mtro-N-nitrosoguanidine or ethylmethanesulfonate or with ultraviolet radiation. Desired mutants form white colonies within 2 to 5 days of incubation in the presence of 4- hydroxybutyrate.
• Example 10 A screening method for other genes encoding 4- hydroxybutyryl CoA biosynthetic enzymes Because applications involving plant systems require DNA with a high GC content, alternative 4-hydroxybutyryl CoA biosynthetic genes need to be identified and isolated. The low GC content of the hbcT gene would makes it a useful probe for identification and isolation of homologous genes from other AT-rich DNA containing microorgamsms. HbcT genes with a high GC content however will not be identified by this method. E. coli strains that have a chromosomally integrated phbC gene encoding PHA synthase can be used to screen for such genes.
• MBX379 for instance, this strain is able to produce a P4HB polymer on agar plates containing 4-hydroxybutyrate in addition to the common nutrients.
• the formation of P4HB gives the colony an easily distinguishable white phenotype.
• gene libraries of PHB-co-4HB producing organisms such as R. eutropha, A. latus, P. acidovorans, C. testosteroni and others are introduced into MBX379 or similar strains and directly plated on 4HB containing growth medium. White colonies are selected and the composition of the accumulated PHA is determined.
• Gene libraries are readily constructed from organisms of choice by isolating genomic DNA and cloning a representative collection of DNA fragments in plasmid vectors.
• Libraries should have 5,000 to 100,000 individual colonies. Libraries are either made as a broad host range library in vectors such as pLAFR3 or as E. coli libraries in vectors such as pUC19, pBR322. Depending on the type of library and the method of introducing the library in the host of choice, the genomic DNA fragments are either large (17-30 kb) or relatively small (2-6 kb). Libraries are introduced into the screening strains by electroporation, transformation or conjugation, dependent on the host and the vector used. In addition to alternative 4-hydroxybutyryl CoA transferases, acyl CoA synthetases able to utilize 4-hydroxybutyrate as a substrate will be isolated by this method.
• genes encoding enzymes with such general activities are fadD, involved in uptake of long-side chain fatty acids, atoDA, involved in uptake of acetoacetate and short side chain fatty acids, catE, involved in degradation of aromatics, aceAB, encoding succinyl CoA synthetase, acsA and acsB encoding acetyl CoA synthetases and homologs of such genes.
• the substrate specificity of these enzymes may be expanded to include 4-hydroxybutyrate by introducing plasmids with randomly mutagenized acyl CoA synthetase or transferase genes.
• the ygfH gene from E.
• Example 11 Endogenous synthesis of 4HB-CoA from a-ketoglutarate ⁇ -Ketoglutarate is a cellular metabolite that can be converted to 4HB as shown in Figure 7.
• the pathway consists of a cyclic reaction catalyzed by the gabT, gadA/gadB and gdhA gene products.
• succinic acid semialdehyde from this cycle is favored once the product is further converted to 4HB-CoA by 4-HB dehydrogenase and 4HB-CoA transferase, and polymerized into a PHA by PHA synthase.
• 4hbD was obtained from pCK3 by PCR using the primers: 4HBD-N: 5 ' CTCTG AATTC AAGGAGGAAAAAATATG AAGTTAT TAAAATTGGC (EcoRl)
• 4HBD-C 5 'TTTCTCTGAGCTCGGGATATTTAATGATTGTAGG
• the TD or TP r TD fragment was excised as a Avrll fragment and ligated into Avrll digested pUTkan (pMUX-TD and pMUX-TPj-TD).
• This plasmid allows random insertion of the TD/TPl - TD construct in the chromosome of E. coli.
• Expression of integrated TD is driven by an endogenous promoter whereas expression of integrated TPj-TD is driven by P, .
• Recombinants in which the construct had integrated were selected for their ability to grow on 4-hydroxybutyrate as sole carbon source. No antibiotic resistance marker was required to select the desired insertions.
• genes encoding enzymes that facilitate conversion of succinic semialdehyde to 4-hydroxybutyryl CoA can be isolated routinely by complementation. After introduction of 4hbD homologs such genes confer on wild-type E. coli strains the ability to use 4HB as sole carbon source.
• gdhA- gadA- gabT An operon consisting of gdhA- gadA- gabT was created in plasmid pUC18Sfi and inserted in the E. coli chromosome using the pUTkan vector. Recipients of the construct were isolated on ⁇ 2/glycerol/_ ⁇ - hydroxybutyrate /Nl plates. Because the recipient strain is unable to use ⁇ -hydroxybutyrate as nitrogen source (due to a gabT mutation), only those strains that express the operon grow on this medium.
• the gdhA gene was obtained from the E. coli chromosome using PCR and the following primers: GH-Up: 5' AACGAATTCAATTCAGGAGGTTTTTATGGATCAGAC ATATTCTCTGGAGTC (EcoRT)
• GH-Dn 5' TTGGGAGCTCTACAGTAAGAAATGCCGTTGG (Sad).
• the gadB gene was obtained from the E. coli chromosome using PCR and the following primers: GB-Up: 5' TAAGAGCTCAATTCAGGAGGTTTTTATGGATAAGAA GCAAGTAACGGATTTAAGG (Sad)
• GB-Dn 5' TTCCCGGGTTATCAGGTATGCTTGAAGCTGTTCTGT TGGGC (Xmal).
• the gabT gene was obtained from the E. coli chromosome using PCR and the following primers: GT-Up: 5' TCCGGATCCAATTCAGGAGGTTTTTATGAACAGCAA
• TAAAGAGTTAATGCAG (BamHT) GT-Dn: 5' GATTCTAGATAGGAGCGGCGCTACTGCTTCGCC
• DNA sequence information used to design the above primers was from GenBank, accession numbers: K02499 (gdhA), M84025 and X71917 (gadB), M88334 (gabT).
• the operon was excised as an EcoRI-Sall fragment and cloned in pMSXTP, (pMSX-TP r ABT). Either the ABT or TP r ABT insert was moved to pUTkan to allow insertion of the gdhA- gadA- gabT operon in the chromosome of a gabT mutant of E. coli MBX245. Successful insertions were selected on E2/glycerol/ ⁇ -hydroxybutyrate /Nl plates.
• gabT expression allows the use of ⁇ -hydroxybutyrate as nitrogen source, genes that express this function can be easily selected for on minimal medium plates in which ⁇ -hydroxybutyrate serves as the only nitrogen source. Expression of gabT at the end of the operon necessitates the transcription of the upstream genes for which no direct selection is available.
• Glutamate dehydrogenase functions in this pathway as a source to provide glutamate in catalytic amounts. If sufficient glutamate is present, additional GdhA activity may not be required and incorporation of this gene in the described constructs is therefore optional.
• Example 12 Endogenous synthesis of 4HBCoA from GABA precursors
• the common metabolite GABA is derived from glutamate and is normally metabolized via succinic semialdehyde to succinate in central metabolism. It may be desirable to improve the pathways to GABA to achieve high levels of the intermediates for P4HB formation. Besides the direct conversion of ⁇ -ketoglutarate to glutamate by glutamate dehydrogenase, this conversion is also part of many transamination reactions for instance with substrates such as glutamine and other amino acids, or putrescine.
• HbcT is not required for E. coli to grow on 4-hydroxybutyrate when catl, 4hbD and sucD are introduced (S ⁇ hling and Gottschalk, 1996, J. Bacteriol. 178, 871-880) possibly because the reverse action of SucD, 4HBD and Catl converts 4HB to succinate, a central metabolite in E. coli.
• these genes together allow the conversion of succinate to 4-HB.
• the pathway as depicted in Figure 4 can then be assembled from the catl, sucD, 4hbD and hbcT genes of C. kluyveri. Alternatively, these genes can be isolated from other Clostridium species such as C. aminobutyricum.
• E. coli does have a succinyl-CoA:CoA transferase itself (sucCD; Mat- Jan et al. Mol. Gen. Genet. (1989) 215: 276-280), it is desirable to introduce this gene from another source because this activity is not prominent in E. coli (Amarasingham and Davis, J. Biol. Chem. (1965) 240: 3664-3668). Alternatively, expression of the E. coli gene can be optimized for the current application.
• a BamHI-Pstl fragment from pCK3 containing orfY, catl, sucD and the 5' end of 4hbD was ligated in the corresponding sites of pMSXcat (pMSX-YlD).
• the 4hbD gene was completed by inserting the Pstl-Sad fragment of pMSX-D in Pstl-Sphl digested pMSX-YlD (pMSX-YIDD). To achieve this, both fragments in this ligation were T4 polymerase treated after the Sphl and Sad digestions to create blunt ends before an additional Pstl digestion was started.
• OrfY in pMSX-YIDD was replaced with hbcT by digesting pMSX-YIDD with BamHI and Pad, followed by blunt ending the fragment with Klenow/T4 polymerase and dephosphorylation, and then ligation of the SspI/EcoRI, Klenow treated hbcT fragment into this vector (pMSX-TIDD).
• a fragment providing the regulatory sequences, terminator and promoter was inserted as a blunt ended fragment in the Smal site of pMSX-TIDD.
• An integration plasmid for this operon was constructed by cloning the insert of pMSX-TIDD as an Sfil fragment into pUTkan.
• Example 14 Improved endogenous synthesis of 4HBCoA
• the aspC gene maps to minute 21.1 and is therefore linked to the TnlO (Tc) marker in CAG 12094 (zcc-282 at 22.25 minutes) or CAG18478 (zbj-1230 at 20.00 minutes) and to the TnlOKm marker in CAG12130 (zcb-3111 at minute 21.00).
• Tc TnlO
• CAG 12094 zcc-282 at 22.25 minutes
• CAG18478 zbj-1230 at 20.00 minutes
• TnlOKm marker in CAG12130
• No mutations in the gabD gene are known and deletion of this activity can be achieved by cloning the gene by PCR, insertion of a genetic marker such as antibiotic resistance, integration using recBC strains or vectors constructed for this purpose such as pMAK705 and finally, bacteriophage PI transduction to transfer the gene to the desired host.
• Example 15 Expression of A PHA synthase and 4-hydroxybutyryl- CoA transferase in Oilseed Crops.
• Methods for the identification of genes encoding enzymes capable of forming 4-hydroxybutyryl-CoA from 4-hydroxybutyric acid (i.e. , having 4-hydroxybutyryl-CoA transferase activity) which can be expressed in a transgenic plant comprising a PHA synthase transgene were developed by standard procedures. In certain cases, it may also be useful to express other PHA biosynthetic genes such as a ⁇ -ketothiolase and/or acetoacetyl-CoA reductase in the plant crop of interest.
• a gene or genes in the case of a PHA synthase with more than one subunit, encoding a PHA synthase from a microorganism into plant cells and obtain the appropriate level of production of the PHA synthase enzyme.
• additional PHA biosynthetic genes eg. an acetoacetyl-CoA reductase gene, a 4- hydroxybutyryl-CoA transferase gene or other genes encoding enzymes required to synthesize the substrates for the PHA synthase enzymes.
• More recent technology enables the direct insertion of foreign genes directly into the plastid chromosome by recombination (Svab et. al. , 1990, Proc. Natl;. Acad. Sci. USA. 87: 8526-8530; McBride et. al., 1994, Proc. Natl. Acad Sci. USA. 91: 7301-7305).
• the prokaryotic nature of the plastid RNA and protein synthesis machinery also allows for the expression of microbial operons such as for example the phbCA operon of A. eutrophus. This technology allows for the direct incorporation of a series of genes encoding a multi-enzyme pathway into the plastid genome.

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Genetics & Genomics (AREA)
• Organic Chemistry (AREA)
• Engineering & Computer Science (AREA)
• Wood Science & Technology (AREA)
• Zoology (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Biotechnology (AREA)
• General Engineering & Computer Science (AREA)
• Biomedical Technology (AREA)
• Microbiology (AREA)
• Biochemistry (AREA)
• Molecular Biology (AREA)
• General Health & Medical Sciences (AREA)
• Medicinal Chemistry (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Nutrition Science (AREA)
• General Chemical & Material Sciences (AREA)
• Polymers & Plastics (AREA)
• Cell Biology (AREA)
• Physics & Mathematics (AREA)
• Biophysics (AREA)
• Plant Pathology (AREA)
• Preparation Of Compounds By Using Micro-Organisms (AREA)
• Micro-Organisms Or Cultivation Processes Thereof (AREA)
• Polyesters Or Polycarbonates (AREA)
• Enzymes And Modification Thereof (AREA)
• Biological Depolymerization Polymers (AREA)

Priority Applications (5)

Applications Claiming Priority (2)

Publications (2)

Family

ID=22022544

Family Applications (1)

Country Status (8)

Cited By (30)

Families Citing this family (129)

Family Cites Families (31)

• 1998
  • 1998-09-18 AT AT98948384T patent/ATE323152T1/de not_active IP Right Cessation
  • 1998-09-18 AU AU94968/98A patent/AU725516B2/en not_active Ceased
  • 1998-09-18 US US09/156,809 patent/US6316262B1/en not_active Expired - Lifetime
  • 1998-09-18 DE DE69838768T patent/DE69838768T2/de not_active Expired - Lifetime
  • 1998-09-18 CA CA2303070A patent/CA2303070C/en not_active Expired - Fee Related
  • 1998-09-18 WO PCT/US1998/019659 patent/WO1999014313A2/en not_active Ceased
  • 1998-09-18 DE DE69834199T patent/DE69834199T2/de not_active Expired - Lifetime
  • 1998-09-18 EP EP98948384A patent/EP1015565B1/en not_active Expired - Lifetime
  • 1998-09-18 JP JP2000511853A patent/JP2001516574A/ja not_active Withdrawn
• 2001
  • 2001-11-09 US US10/006,915 patent/US6689589B2/en not_active Expired - Lifetime
• 2003
  • 2003-05-09 JP JP2003132325A patent/JP2003310262A/ja not_active Withdrawn
• 2004
  • 2004-02-06 US US10/773,916 patent/US7081357B2/en not_active Expired - Fee Related
• 2005
  • 2005-10-07 US US11/245,891 patent/US7229804B2/en not_active Expired - Fee Related
• 2007
  • 2007-04-16 US US11/735,888 patent/US20100093043A1/en not_active Abandoned
  • 2007-10-25 US US11/924,531 patent/US20110008856A1/en not_active Abandoned
• 2008
  • 2008-12-24 JP JP2008328226A patent/JP2009082147A/ja active Pending
  • 2008-12-24 JP JP2008328227A patent/JP2009171960A/ja active Pending

Also Published As

Similar Documents

Legal Events